MARKET

OSUR

OSUR

OraSure Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.95
+0.63
+6.10%
Opening 12:29 02/24 EST
OPEN
10.78
PREV CLOSE
10.32
HIGH
11.06
LOW
10.50
VOLUME
546.72K
TURNOVER
--
52 WEEK HIGH
19.75
52 WEEK LOW
5.23
MARKET CAP
785.47M
P/E (TTM)
-48.2591
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Global Osteocalcin Assay Market 2020 Key Players, Comprehensive Research, SWOT Analysis and Forecast by 2025
Feb 22, 2021 (CDN Newswire via Comtex) -- Global Osteocalcin Assay Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 is the...
CDN Newswire · 1d ago
Global Osteocalcin ELISA Kit Market 2020 Industry Analysis by Key Players, Product Type, Application, Regions and Forecast to 2025
Feb 22, 2021 (CDN Newswire via Comtex) -- The most recent report namely Global Osteocalcin ELISA Kit Market 2020 by Manufacturers, Regions, Type and...
CDN Newswire · 1d ago
OraSure Technologies (OSUR) Reports Next Week: Wall Street Expects Earnings Growth
Zacks.com · 1d ago
Infectious Disease Testing Device Market Size Surpass Around US$ 25.9 Bn by 2026
Feb 20, 2021 (Market Insight Reports) -- According to Qy research medical Reports, the global Infectious Disease Testing Device market size was valued at US$...
Market Insight Reports · 3d ago
Quidel leads a slump in COVID-19 test makers
Quidel Corporation ([[QDEL]] -10.9%) has failed to meet the consensus revenue estimates in Q4 2020 despite the surging pandemic driving a ~80.6% YoY sequential growth in revenue from COVID-19 products.Today,
Seekingalpha · 4d ago
Point Of Care Testing(Poct) Market Share 2021, Size, Industry Growth by Global Major Companies Profile, Competitive Landscape and Key Regions 2025.
Feb 19, 2021 (The Expresswire) -- Global "Point Of Care Testing(Poct) Market" (2021-2025) Research Report is deep analysis by historical and current status...
The Express Wire · 5d ago
Point of Care Diagnostics Market Insights 2021 With Regional Overview, Investment Opportunities, Share, Gross Margin, Top Key Players, Supply Demand Scenario, Pricing Analysis and Forecast to 2026
Feb 19, 2021 (The Expresswire) -- Global “Point of Care Diagnostics Market” report is extensive significant analyses of the Point of Care Diagnostics...
The Express Wire · 5d ago
COVID-19 IgM or IgG Antibody Rapid Test Kits Market Growing Factors Size 2021: Global Opportunities by Leading Players, Top Countries Data, Demand Status, Regional Overview by CAGR Value and Share Analysis till 2025
The Express Wire · 5d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OSUR. Analyze the recent business situations of OraSure Tech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OSUR stock price target is 18.86 with a high estimate of 34.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 334
Institutional Holdings: 75.17M
% Owned: 104.80%
Shares Outstanding: 71.73M
TypeInstitutionsShares
Increased
62
7.60M
New
59
-2.85M
Decreased
59
5.95M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.99%
Healthcare Equipment & Supplies
+0.89%
Key Executives
Chairman/Independent Director
Michael Celano
President/Chief Executive Officer/Director
Stephen Tang
Chief Financial Officer
Roberto Cuca
Executive Vice President
Lisa Nibauer
Executive Vice President
Kathleen Weber
Senior Vice President/Chief Compliance Officer/General Counsel/Secretary
Jack Jerrett
Vice President - Finance/Controller
Michele Miller
Director
Lelio Marmora
Independent Director
Mara Aspinall
Independent Director
James Datin
Independent Director
Eamonn Hobbs
Independent Director
Ronny Lancaster
Independent Director
David Shulkin
  • Dividends
  • Splits
  • Insider Activity
No Data
About OSUR
OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing.

Webull offers kinds of OraSure Technologies, Inc. stock information, including NASDAQ:OSUR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OSUR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OSUR stock methods without spending real money on the virtual paper trading platform.